Jinjuan Wang

发表

from the Cell Membrane TCR Is Modulated by Target Epitope Distance Antigen Sensitivity of CD22-Specific Chimeric

P. Greenberg, E. James, S. Forman, 2011 .

Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane1

P. Greenberg, S. Forman, M. Jensen, 2008, The Journal of Immunology.

Antigen Sensitivity of CD 22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane 1

P. Greenberg, S. Forman, M. Jensen, 2008 .

Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.

S. Riddell, P. Greenberg, S. Forman, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains.

S. Riddell, P. Greenberg, S. Forman, 2007, Human gene therapy.

Mathematical Modeling of Chimeric TCR Triggering Predicts the Magnitude of Target Lysis and Its Impairment by TCR Downmodulation

P. Greenberg, S. Forman, M. Jensen, 2010, The Journal of Immunology.

A comparison of efficacy and safety of complementary and alternative therapies for severe mycoplasma pneumonia in children

Jialin Zheng, Jinjuan Wang, Hongan He, 2021, Medicine.

Comparative efficacy and safety of traditional Chinese patent medicine in the treatment of Mycoplasma pneumoniae pneumonia in children

Jialin Zheng, Jinjuan Wang, Hongan He, 2020, Medicine.

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.

Jinjuan Wang, Xiaojun Qian, D. Maloney, 2012, Blood.

Prediction of Renal Damage in Children with Henoch-Schönlein Purpura Based on Machine Learning

Jinjuan Wang, Hui-min Chu, Yu-xuan Pan, 2022 .

CD20-speciﬁc adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

D. Maloney, S. Riddell, P. Greenberg, 2012 .

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.

Jinjuan Wang, Brent L Wood, Xiaojun Qian, 2008, Blood.

Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma

S. Riddell, M. Jensen, O. Press, 2013, PloS one.

CD20-specific T cells mantle cell lymphoma using genetically modified autologous Adoptive immunotherapy for indolent non-Hodgkin lymphoma and

B. Wood, S. Riddell, P. Greenberg, 2011 .

Downmodulation Lysis and Its Impairment by TCR Triggering Predicts the Magnitude of Target Mathematical Modeling of Chimeric TCR

P. Greenberg, S. Forman, M. Jensen, 2010 .

CD 20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD 28 and 4-1 BB domains : pilot clinical trial results

D. Maloney, S. Riddell, P. Greenberg, 2012 .

results antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial CD20-specific adoptive immunotherapy for lymphoma using a chimeric

D. Maloney, S. Riddell, P. Greenberg, 2012 .

53. Preliminary Results of a Pilot Phase I Clinical Trial of Adoptive Immunotherapy for B Cell Lymphoma Using CD8+ T Cells Genetically Modified To Express a Chimeric T Cell Receptor Recognizing CD20

S. Riddell, P. Greenberg, J. Pagel, 2006 .

Prediction of renal damage in children with IgA vasculitis based on machine learning

Jinjuan Wang, Yueli Pan, H. Chu, 2022, Medicine.